The project objectives for Linda Page to follow were to "Assess and report on documents relating to previous Government policy on the safe use of imported and domestic blood products during the period 1970 to 1985 when BPL commenced general issue of 8Y heat-treated factor VIII. Specifically the inactivation of blood products for NANBH."